Annals of Internal Medicine

Papers
(The H4-Index of Annals of Internal Medicine is 91. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application4243
Prevalence of Asymptomatic SARS-CoV-2 Infection1859
Autopsy Findings and Venous Thromboembolism in Patients With COVID-191609
Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure1064
Attitudes Toward a Potential SARS-CoV-2 Vaccine885
Psychological Impact of the COVID-19 Pandemic on Health Care Workers in Singapore777
Racial and Ethnic Disparities in COVID-19–Related Infections, Hospitalizations, and Deaths690
Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome569
Worldwide Effect of COVID-19 on Physical Activity: A Descriptive Study555
Collision of the COVID-19 and Addiction Epidemics511
Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors490
Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus 2447
Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers429
Sixty-Day Outcomes Among Patients Hospitalized With COVID-19413
Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization402
COVID-19 and the Risk to Health Care Workers: A Case Report397
Awareness, Attitudes, and Actions Related to COVID-19 Among Adults With Chronic Conditions at the Onset of the U.S. Outbreak394
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19392
The Proportion of SARS-CoV-2 Infections That Are Asymptomatic372
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19330
Systemic Lupus Erythematosus294
The Unrecognized Prevalence of Primary Aldosteronism288
A War on Two Fronts: Cancer Care in the Time of COVID-19281
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series269
An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19245
Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers245
Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2240
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy238
SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection234
Knowledge and Perceptions of COVID-19 Among the General Public in the United States and the United Kingdom: A Cross-sectional Online Survey234
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19215
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia213
Probable Evidence of Fecal Aerosol Transmission of SARS-CoV-2 in a High-Rise Building181
Supporting Clinicians During the COVID-19 Pandemic178
Locally Informed Simulation to Predict Hospital Capacity Needs During the COVID-19 Pandemic177
SARS-CoV-2–Positive Sputum and Feces After Conversion of Pharyngeal Samples in Patients With COVID-19166
When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis165
This Time Must Be Different: Disparities During the COVID-19 Pandemic165
Contact Settings and Risk for Transmission in 3410 Close Contacts of Patients With COVID-19 in Guangzhou, China164
Reduced In-Person and Increased Telehealth Outpatient Visits During the COVID-19 Pandemic160
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes157
The Role of Medical Students During the COVID-19 Pandemic155
Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection154
COVID-19: Peer Support and Crisis Communication Strategies to Promote Institutional Resilience151
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know150
COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings149
The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs148
Depression147
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19147
Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19143
Chronic Obstructive Pulmonary Disease142
Fibromyalgia141
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19141
Patient Trajectories Among Persons Hospitalized for COVID-19140
Development and Validation of a Modified Full Age Spectrum Creatinine-Based Equation to Estimate Glomerular Filtration Rate135
Conversion of Urine Protein–Creatinine Ratio or Urine Dipstick Protein to Urine Albumin–Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis129
Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness126
Ventilator Triage Policies During the COVID-19 Pandemic at U.S. Hospitals Associated With Members of the Association of Bioethics Program Directors126
COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults125
Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020122
How Should U.S. Hospitals Prepare for Coronavirus Disease 2019 (COVID-19)?119
Adverse Effects of Low-Dose Methotrexate115
Cross-sectional Assessment of COVID-19 Vaccine Acceptance Among Health Care Workers in Los Angeles115
Safety and Immunogenicity of Anti–SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants114
Myasthenia Gravis Associated With SARS-CoV-2 Infection113
Racial Disparities in COVID-19 Testing and Outcomes113
Isradipine Versus Placebo in Early Parkinson Disease112
Caution Warranted: Using the Institute for Health Metrics and Evaluation Model for Predicting the Course of the COVID-19 Pandemic106
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis106
Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus 2105
Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing?105
Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings104
Detection of Monkeypox Virus in Anorectal Swabs From Asymptomatic Men Who Have Sex With Men in a Sexually Transmitted Infection Screening Program in Paris, France104
Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting101
Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline101
Sex and Gender Differences in Health: What the COVID-19 Pandemic Can Teach Us101
Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments100
Communication Skills in the Age of COVID-19100
Reporting, Epidemic Growth, and Reproduction Numbers for the 2019 Novel Coronavirus (2019-nCoV) Epidemic99
Effectiveness of Surgical and Cotton Masks in Blocking SARS–CoV-2: A Controlled Comparison in 4 Patients99
Intersecting U.S. Epidemics: COVID-19 and Lack of Health Insurance98
Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults98
A SARS-CoV-2 Cluster in an Acute Care Hospital98
Spatial Inequities in COVID-19 Testing, Positivity, Confirmed Cases, and Mortality in 3 U.S. Cities95
A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States94
Delirium93
Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-1993
A Novel International Monkeypox Outbreak91
Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis91
SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting91
Coronavirus Disease 2019 (COVID-19): Protecting Hospitals From the Invisible91
0.030773162841797